Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GF.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GF.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GF.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GF.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.172EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.172EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.172ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.172ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.172EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.172EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.172ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.172ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.110EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.110EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.110ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.110EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.110EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.110ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.110ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.320EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.320EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.320ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.320ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.320EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.320EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.320ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.320ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
A.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
A.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
A.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
A.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.91EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.91EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.91ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.91ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.91EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.91EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.91ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.91ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used